Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001042408 | SCV001206086 | uncertain significance | X-linked agammaglobulinemia with growth hormone deficiency | 2019-05-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has been observed to segregate with X-linked agammaglobulinemia in families (PMID: 12655572, Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with leucine at codon 623 of the BTK protein (p.Ser623Leu). The serine residue is moderately conserved and there is a large physicochemical difference between serine and leucine. |
Gene |
RCV003153903 | SCV003842563 | likely pathogenic | not provided | 2022-09-19 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12655572, 18677443) |